fda pulls semaglutide Wegovy becomes first GLP-1RA to gain FDA MASH approval

The FDA has received reports of adverse events after patients used compounded versions of semaglutide. Some compounders may also be using unapproved salt forms., Patients should avoid compounded

20.75

★★★★☆4.8 (126)

They Lost Weight with Compounded GLP-1s. New FDA Rule May Change That

27.06

★★★★★4.9 (98)

Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s

23.30

★★★★★5.0 (157)

FDA crackdown on off-brand Ozempic products set to take effect, threatening supply and access for many

29.35

★★★★★4.7 (84)

FDA Approves Wegovy Weight-Loss Pill

21.37

★★★★★4.9 (203)

The FDA has removed semaglutide injection products (GLP-1) from the shortage list, ending the temporary rule that allowed pharmacies to compound these medications, often used for weight loss. Compounded drugs are custom-made

21.30

★★★★★5.0 (176)

FDA Clears Semaglutide For Cardiac Risk Reduction in Diabetic Patients

22.27

★★★★★4.8 (132)